PMID- 19468008 OWN - NLM STAT- MEDLINE DCOM- 20090824 LR - 20191210 IS - 1475-3901 (Electronic) IS - 1475-3898 (Linking) VI - 18 IP - 3 DP - 2009 Jun TI - Long-term effects of a multifaceted intervention to encourage the choice of the oral route for proton pump inhibitors: an interrupted time-series analysis. PG - 232-5 LID - 10.1136/qshc.2007.023887 [doi] AB - PROBLEM: Drugs are often given intravenously even when the patient is able to swallow and when an oral form would be more cost-effective. DESIGN: Evaluation of the impact of a multifaceted intervention on the early switch from intravenous to oral administration of proton pump inhibitors (PPI) in a hospital setting. The interrupted time series of intravenous PPI consumption was analysed. BACKGROUND AND SETTING: At a French University Hospital, the Drug Committee, composed of multidisciplinary pharmacy and medical staff, addressed the issue of increasing consumption of intravenous PPI drugs (May 2003). STRATEGY FOR CHANGE: Letters to department heads, academic analyses from members of the Drug Committee, paper reminders at the point of care and audit-feedbacks by pharmacists. Monitoring of consumption and repeated reminder letters were planned. EFFECT OF CHANGE: The consumption of PPI was stable before the first intervention (mean level: 954 units/month). An immediate decrease occurred after the first Drug Committee letter (30% relative reduction, 95% CI -16% to -46%; p<0.001) with a significant trend change during the first multifaceted intervention (-24 units/month, 95% CI -42 to -7; p = 0.007). After the end of the outreach visits (July 2004), the consumptions increased (+32 units/month, 95% CI: 14 to 50, p<0.001). The second intervention had no significant impact. LESSONS LEARNT: A complex intervention (audit, feedbacks, outreach visits) had an effect on practice. It was not sustained even after a less resource-intensive intervention. Other types of interventions are needed that could be continuously implemented to improve ordering practices long term. FAU - Colombet, I AU - Colombet I AD - INSERM, UMR_S 872, Paris, France. isabelle.colombet@egp.aphp.fr FAU - Sabatier, B AU - Sabatier B FAU - Gillaizeau, F AU - Gillaizeau F FAU - Prognon, P AU - Prognon P FAU - Begue, D AU - Begue D FAU - Durieux, P AU - Durieux P LA - eng PT - Evaluation Study PT - Journal Article PL - England TA - Qual Saf Health Care JT - Quality & safety in health care JID - 101136980 RN - 0 (Proton Pump Inhibitors) MH - Administration, Oral MH - France MH - Guideline Adherence MH - Humans MH - Infusions, Intravenous MH - Practice Patterns, Physicians'/*statistics & numerical data MH - Proton Pump Inhibitors/*administration & dosage MH - Reminder Systems EDAT- 2009/05/27 09:00 MHDA- 2009/08/25 09:00 CRDT- 2009/05/27 09:00 PHST- 2009/05/27 09:00 [entrez] PHST- 2009/05/27 09:00 [pubmed] PHST- 2009/08/25 09:00 [medline] AID - 18/3/232 [pii] AID - 10.1136/qshc.2007.023887 [doi] PST - ppublish SO - Qual Saf Health Care. 2009 Jun;18(3):232-5. doi: 10.1136/qshc.2007.023887.